Skip to content

A study evaluating the antihyperglycemic effect of botanical ingredient-containing food.

A study evaluating the antihyperglycemic effect of botanical ingredient-containing food. - A study evaluating the antihyperglycemic effect of botanical ingredient-containing food.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044484
Enrollment
60
Registered
2021-06-18
Start date
2021-07-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Subjects take control food for 4 weeks. Before and after repeated intake, subjects take Oral Glucose Tolerance Test to measure blood glucose levels. Subjects take test food (containing botanical ingr

Sponsors

Suntory Global Innovation Center Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy male and female subjects whose ages are 20 <= years old <65. (2) Subjects who can visit the specified clinic on the scheduled day. (3) Subjects who agree with the given description and express informed consent via telecommunication and written documents.

Exclusion criteria

Exclusion criteria: (1) Systolic pressure <90 mmHg (2) Subjects who are pregnant or lactating. (3) Subjects who donated over 200ml blood components or whole blood within the past 4 weeks prior to the current study. (4) Male who donated over 400ml whole blood within the past 12 weeks. (5) Female who donated over 400ml whole blood within the past 16 weeks. (6) Male whose blood was collected more than 1200 mL within the last 12 months when the amount of blood sampling in the current study is added. (7) Female whose blood was collected over 800 mL within the last 12 months when the amount of blood sampling in the current study is added. (8) Subjects who are participating in other clinical studies, or who finished clinical study within the last 4 weeks. (9)Subjects a) with disease on heart, liver, kidney or other organs complications. b) with a previous history of disease on circulatory organs. c) who are contracting diabetes. d) with test food allergy. e) whose fasting blood glucose is equivalent to or higher than 140 mg/dL by a finger stick blood test. (10) Subjects who have severe allergic reaction to drug medicine and food. (11) Subjects with a previous history of feeling sick after blood sampling. (12) Subjects who have difficulty in blood sampling from peripheral vein. (13) Subjects who drink over 60 g of alcohol per day on average. (14) Subjects who have irregular eating patterns. (15) Subjects who work irregular shifts or at midnight. (16) Subjects whose BMI is less than 18.5 or over 30.0 kg/m2. (17) Subjects who are constantly taking certain drug medicine, or who are expecting taking it within the period of current study, or who have indispensable supplements, functional foods affecting the test results. (18) Subjects who are contracting atopic dermatitis and/or allergy symptoms. (19) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Area under the curve of blood glucose levels after Oral Glucose Tolerance Test

Countries

Japan

Contacts

Public ContactTomoki Uchida

Suntory Global Innovation Center Ltd. Research Institute

Tomoki_Uchida@suntory.co.jp05031820381

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026